Neurol. praxi. 2023;24(6):474-476 | DOI: 10.36290/neu.2023.063

Central retinal artery occlusion as an underestimated form of ischaemic stroke

MUDr. Ing. David Černík, MBA, Ph.D.1, MUDr. Jiří Neumann, FESO2, MUDr. Jarmila Neradová1
1 Komplexní cerebrovaskulární centrum, Neurologické oddělení, Masarykova nemocnice Ústí nad Labem, o. z., Krajská zdravotní, a. s.
2 Iktové centrum, Neurologické oddělení, Nemocnice Chomutov, o. z., Krajská zdravotní, a. s.

Central retinal artery occlusion can occur secondary to embolism from an unstable atherosclerotic plaque of the internal carotid artery. In our case report, monocular visual loss was the initial presentation of a severe course of ischaemic stroke which required urgent management with mechanical thrombectomy. The aim of the paper is to highlight the often underestimated severity of this condition. In our opinion, central retinal artery occlusion should be managed in an acute mode, without delay, and with the involvement of emergency medical services, just like any other stroke. In spite of the debate in both the Czech and worldwide professional community, no consensus has so far been available on the approach to this clinical entity.

Keywords: central retinal artery, stroke, mechanical thrombectomy, intravenous thrombolysis.

Received: July 28, 2023; Revised: August 29, 2023; Accepted: September 8, 2023; Prepublished online: September 8, 2023; Published: December 7, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Černík D, Neumann J, Neradová J. Central retinal artery occlusion as an underestimated form of ischaemic stroke. Neurol. praxi. 2023;24(6):474-476. doi: 10.36290/neu.2023.063.
Download citation

References

  1. Berge E, Whiteley W, Audabert H, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021;6(1):I­‑LXII.doi:01177/2396987321989865. Go to original source... Go to PubMed...
  2. Flaxel CJ, Adelman RA, Bailey ST, et al. Retinal and ophtalmic artery occlusions prefered practice pattern. Ophthmalmol. 2020;127:259-287. Go to original source... Go to PubMed...
  3. Hayreh SS. Central retinal artery occlusion. Indian J Ophthalmol. 2018;66(12):1684-1694. doi: 10.4103/ijo.IJO_1446_18. Go to original source... Go to PubMed...
  4. Huang L, Wang Y, Zhang R. Intravenous thrombolysis in patients with central retinal artery occlusion: a systematic review and meta­‑analysis. J Neurol. 2022;269(4):1825-1833. doi: 10.1007/s00415-021-10838-6. Go to original source... Go to PubMed...
  5. Hyungtaek T, Jan J, Choi YS, et al. Retinal artery occlusion and the risk of stroke development. Twelve­‑year nationwide cohort study. Stroke. 2016;47(2):376-82. Go to original source... Go to PubMed...
  6. Lee KE, Tschoe C, Coffman SA, et al. Management of Acute Central Retinal Artery Occlusion, a "Retinal Stroke": An Institutional Series and Literature Review. J Stroke Cerebrovasc, DiS. 2021;30(2):105531. doi:10.1016/j.jstrokecerebrovasdis.2020.105531. Go to original source... Go to PubMed...
  7. Mac Grory B, Schrag M, Biousse V, et al. Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association [published correction appears in Stroke. 2021;52(6):e309]. Stroke. 2021;52(6):e282-e294. doi:10.1161/STR.0000000000000366. Go to original source... Go to PubMed...
  8. Neumann J, Šaňák D, Tomek A, et al. Doporučení pro intravenózní trombolýzu v léčbě akutního mozkového infarktu - verze 2021. Cesk Slov Neurol N. 2021;84/117(3):291-299.
  9. Park SJ, Choi N­‑K, Yang BR, et al. Risk and risk periods for stroke and acute myocardial infarction in patients with central retinal artery occlusion. Ophthalmology. 2015;122(11):2336-43. Go to original source... Go to PubMed...
  10. Youn TS, Lavin P, Patrylo M, et al. Current treatment of central retinal artery occlusion: a national survey. J Neurol. 2018;265(2):330-335. doi: 10.1007/s00415-017-8702-x. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.